Lori Jones

Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer

Eric J. Small, Paul F. Schellhammer, Celestia S. Higano et al. · Journal of Clinical Oncology · 2006 · 1.1K citations

Medicine, Oncology, Urology +16

Outcomes of acute leukemia patients transplanted with naive T cell–depleted stem cell grafts

Marie Bleakley, Shelly Heimfeld, Keith R. Loeb et al. · Journal of Clinical Investigation · 2015 · 270 citations · Full text

Life Sciences, Hematology, Immunology +16

Peripheral Clonal Elimination of Functional T Cells

Lori Jones, L. Thomas Chin, Dan L. Longo et al. · Science · 1990 · 210 citations

Life Sciences, Immunology, Adaptive Immunity +16

Immunotherapy (APC8015, Provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen‐independent prostate cancer: A phase 2 trial

Patrick Burch, Gary A. Croghan, Dennis A. Gastineau et al. · The Prostate · 2004 · 190 citations

Medicine, Immunology, Oncology +17

Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial.

Patricia A. Lodge, Lori Jones, Robert Bader et al. · PubMed · 2000 · 163 citations

Life Sciences, Immunology, Oncology +17